"The scientists of UF Scripps Biomedical Research work at the exciting interface of chemistry and biology. We blend leading-edge expertise and resources to illuminate the molecular basis of health and disease. Employing unique and advanced tools of drug discovery, we pursue novel treatments for a world of unmet medical needs."

During the past decade, Drug Study Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 12 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drug Study Institute" #1 sponsor was "Purdue Pharma LP" with 6 trials, followed by "AstraZeneca" with 4 trials sponsored, "BioDelivery Sciences International" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Sucampo Pharma Americas, LLC" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Study Institute" #1 collaborator was "Integrium" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Drug Study Institute" are "Osteoarthritis" (4 trials), "Arthritis, Rheumatoid" (3 trials), "Low Back Pain" (3 trials), "Back Pain Lower Back Chronic" (2 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials). Many other conditions were trialed in "Drug Study Institute" in a lesser frequency.

Most popular intervention types in "Drug Study Institute" are "Drug" (23 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "AC2993" (4 trials), "Buprenorphine" (4 trials), "Buprenorphine transdermal patch" (3 trials) and "BI 695501" (2 trials). Other intervention names were less common.

The vast majority of trials in "Drug Study Institute" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Drug Study Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Drug Study Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Drug Study Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".